

662 A. Kotnis et al. Review. NHEF and CSR

Inhibitors of PARP-1 have been found to increase IgA Barlow, C. et al. 1996 Atm-deficient mice: a paradigm of
switching in a B cell line and enhance IgG1 switching in ataxia telangiectasia. Cell 86, 159-171. (doi:10.1016/
activated splenic B cells (Shockett & Stavnezer 1993). S0092-8674(00)80086-0) ; ;

This may imply that PARP-1 would normally inhibit Beamish, H. J., Jessberger, R., Riballo, E., Priestley, As
or compete with other factors that participate in the Blunt, T., Kysela, B. & Jeggo, P. A. 2000 The C-terminal
predominant NHEJ pathway during CSR, which fits conserved domain of DNA-PKcs, missing in the SCID
well with the hypothesis that it may be a component of mouse, is required for kinase activity. Nucleic Acids Res. 28,
the A-EJ pathway. Inhibitors of PARP-1 can in fact lead 1506-1513. (doi:10.1093/nar/28.7.1506)

on . : Berkovich, E., Monnat Jr, R. J. & Kastan, M. B. 2007 Roles
to the activation of ATM in other DNA repair process of ATM and NBS1 in chromatin structure modulation

such as HR (Bryant & Helleday 2006). It would and DNA double-strand break repair. Nat. Cell Biol. 9,
therefore be of considerable interest to test the effect of 683-690. (doi:10.1038/ncb1599)

PARP-1 in CSR on an NHEJ-deficient background. Blunt, T,, Gell, D., Fox, M., Taccioli, G. E., Lehmann, A. R.,
Both ligases I and III seem to be required for Jackson, S. P. & Jeggo, P. A. 1996 Identification of a
microhomology-mediated end joining (Liang er al. nonsense mutation in the carboxyl-terminal region of
2008) but which of the two ligases is involved in A-EJ DNA-dependent protein kinase catalytic subunit in the
during CSR remains to be clarified. scid mouse. Proc. Natl Acad. Sci. USA 93, 10 285-10 290.